Perspectives on Influenza Virus Infection
Journal
Pediatrics and Neonatology
Journal Volume
50
Journal Issue
2
Pages
41-43
Date Issued
2009
Author(s)
SDGs
Other Subjects
adamantane derivative; amantadine; antivirus agent; M2 ion channel inhibitor; oseltamivir; protein M2; rimantadine; sialidase inhibitor; unclassified drug; zanamivir; antiviral activity; bacterial pneumonia; central nervous system disease; diagnostic test; disease course; disease severity; drug choice; drug targeting; editorial; enzyme immunoassay; human; immune deficiency; influenza; Influenza virus A; Influenza virus A H1N1; Influenza virus A H3N2; Influenza virus B; leukopenia; morbidity; mortality; myalgia; myocarditis; myositis; nonhuman; reverse transcription polymerase chain reaction; sensitivity and specificity; virus pneumonia; Adamantane; Adolescent; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Neuraminidase
Type
editorial
